DPP4 and metabolic dysfunction-associated steatotic liver disease: Thus, expression and activity levels of DPP4 have been found to be altered in conditions such as obesity (16), T2DM (17), and non-alcoholic fatty liver disease (NAFLD) (18), all of which indicate that analyses on DPP4 should take into account the context.